The Department of Molecular Medicine (MOMA) at Aarhus University Hospital is highly specialised and renowned within molecular diagnostics and cancer research.

We conduct basic and clinical studies in cancer of the colon, bladder and prostate supported by the bioinformatics group at MOMA. Research is focused on early detection of cancer, identifying markers concerning response to chemotherapy as well as development of new methods in cancer treatment.

MOMA has core centers for next-generation sequencing (NGS), biobanks and STR-profiling.

The laboratory is accredited by the international laboratory standard DS/EN ISO 15189:2013 for medical examination - genetics.

We offer molecular analysis of genes involved in neoplasms and cancer, heart disease, endocrinology and metabolism as a national and international service to clinicians. In 2013, NGS was implemented in clinical practice potentially increasing the diagnostic yield.

MOMA focuses on translational research in particular molecular understanding of cancer, and endocrine diseases. Molecular medicine aims at better diagnosis, treatment and prevention of disease for patients and their families.

MOMA and our collaborators have established biobanks in bladder cancer (1994), colon cancer (1999) and prostate cancer (2002).

The department collaborates with international cancer experts as well as experts at Danish universities and in the biotech industry. Moreover, MOMA develops software applications together with software engineers for patient management and biobanks.